# Today's AI-Generated Trade Recommendations
## Thursday, December 18, 2025
## Generated: 09:27 AM ET

---

## üìä VALIDATION SUMMARY
**Research Sources**: Claude Deep Research + ChatGPT Deep Research
**Validation**: 7-agent multi-agent consensus system
**Risk Controls**: Position sizing, portfolio limits, veto authority

**DEE-BOT**: 6 approved / 0 rejected
**SHORGAN-BOT**: 21 approved / 0 rejected

---

## üõ°Ô∏è DEE-BOT TRADES (Defensive S&P 100)
**Strategy**: LONG-ONLY, Beta-neutral ~1.0
**Capital**: $100,000
**Max Position**: 8%

### SELL ORDERS
| Symbol | Shares | Limit Price | Confidence | Source | Rationale |
|--------|--------|-------------|------------|--------|-----------|
| GOOGL | 10 | $299.50 | 56% | CLAUDE | Exit position on regulatory concerns and lack of dividend in |
| T | 150 | $24.26 | 56% | CLAUDE | Exit high-debt telecom for better quality dividend opportuni |
| WMT | 20 | $115.50 | 56% | CLAUDE | Trim overweight position after 12.6% gain to rebalance portf |
| MRK | 15 | $98.50 | 56% | CLAUDE | Book partial profits on pharma winner up 12% from entry |

### BUY ORDERS
| Symbol | Shares | Limit Price | Stop Loss | Confidence | Source | Rationale |
|--------|--------|-------------|-----------|------------|--------|-----------|
| CVX | 25 | $148.30 | $136.50 | 56% | CLAUDE | Add quality energy exposure with 3.8% yield for diversificat |
| PFE | 100 | $25.22 | $23.20 | 56% | CLAUDE | Oversold pharma with 6.3% yield offers defensive value play |

### REJECTED RECOMMENDATIONS (for transparency)
*All recommendations approved*

---


## üöÄ SHORGAN-BOT TRADES (Catalyst-Driven)
**Strategy**: Event-driven, momentum, HIGH-CONVICTION
**Capital**: $100,000
**Max Position**: 10%

### SELL ORDERS
| Symbol | Shares | Limit Price | Confidence | Source |
|--------|--------|-------------|------------|--------|
| WOLF | 96 | $17.75 | 56% | CLAUDE |
| RGTI | 252 | $24.45 | 56% | CLAUDE |
| QSI | 300 | $1.27 | 56% | CLAUDE |
| ARWR | 48 | $64.40 | 56% | CLAUDE |
| ARQT | 175 | $28.48 | 56% | CLAUDE |
| GKOS | 54 | $115.50 | 56% | CLAUDE |
| SNDX | 110 | $20.08 | 56% | CLAUDE |
| SPY | 18 | $678.40 | 56% | CLAUDE |
| BEAM | 200 | $27.50 | 56% | CLAUDE |
| DOCU | 100 | $69.10 | 56% | CLAUDE |


### BUY ORDERS
| Symbol | Shares | Limit Price | Stop Loss | Confidence | Source |
|--------|--------|-------------|-----------|------------|--------|
| NCNO | 174 | $25.12 | $20.60 | 56% | CLAUDE |
| PRTA | 800 | $9.75 | $8.50 | 56% | CLAUDE |
| MU | 75 | $89.50 | $84.00 | 56% | CLAUDE |
| DNLI | 400 | $16.85 | $14.50 | 56% | CLAUDE |
| BCRX | 1000 | $7.50 | $6.50 | 56% | CLAUDE |
| IMVT | 250 | $26.80 | $23.00 | 56% | CLAUDE |
| FDX | 20 | $286.00 | $295.00 | 56% | CLAUDE |
| NKE | 80 | $78.50 | $82.00 | 56% | CLAUDE |
| XOM | 50 | $119.00 | $124.00 | 56% | CLAUDE |
| MU | 2857 | $3.50 | $1.75 | 56% | CLAUDE |
| MU | 5555 | $1.80 | $1.48 | 56% | CLAUDE |

### üìã TRADE RATIONALE (Event-Driven Analysis)

**NCNO** - BUY_TO_CLOSE
- **Catalyst**: Market catalyst
- **Rationale**: Cover +15.4% profitable short at target
- **Confidence**: 56% (External: 70%, Internal: 23%)

**PRTA** - BUY
- **Catalyst**: Market catalyst (2025-12-26)
- **Rationale**: FDA PDUFA December 26 with 65% approval probability
- **Confidence**: 56% (External: 70%, Internal: 23%)

**MU** - BUY
- **Catalyst**: Market catalyst (2025-12-19)
- **Rationale**: Earnings 12/19 with HBM memory cycle inflection
- **Confidence**: 56% (External: 70%, Internal: 23%)

**DNLI** - BUY
- **Catalyst**: Market catalyst (2026-01-15)
- **Rationale**: ALS drug data Q1 2025 with breakthrough potential
- **Confidence**: 56% (External: 70%, Internal: 23%)

**BCRX** - BUY
- **Catalyst**: Market catalyst (2026-01-08)
- **Rationale**: ORLADEYO sales update January with HAE market expansion
- **Confidence**: 56% (External: 70%, Internal: 23%)

**IMVT** - BUY
- **Catalyst**: Market catalyst (2026-02-15)
- **Rationale**: Phase 3 FcRn data Q1 2025 in competitive landscape
- **Confidence**: 56% (External: 70%, Internal: 23%)

**FDX** - SELL_TO_OPEN
- **Catalyst**: Market catalyst (2025-12-18)
- **Rationale**: SHORT into earnings 12/18 on peak margin concerns
- **Confidence**: 56% (External: 70%, Internal: 23%)

**NKE** - SELL_TO_OPEN
- **Catalyst**: Market catalyst (2025-12-23)
- **Rationale**: SHORT into earnings 12/23 on China weakness
- **Confidence**: 56% (External: 70%, Internal: 23%)

**XOM** - SELL_TO_OPEN
- **Catalyst**: Market catalyst
- **Rationale**: SHORT energy leader on crude oil rollover below $70
- **Confidence**: 56% (External: 70%, Internal: 23%)

**MU** - BUY_TO_OPEN
- **Catalyst**: Market catalyst (2025-12-19)
- **Rationale**: Earnings volatility play with defined risk
- **Confidence**: 56% (External: 70%, Internal: 23%)

**MU** - SELL_TO_OPEN
- **Catalyst**: Market catalyst (2025-12-19)
- **Rationale**: Complete bull call spread for earnings
- **Confidence**: 56% (External: 70%, Internal: 23%)



### REJECTED RECOMMENDATIONS (for transparency)
*All recommendations approved*


---

## üìã EXECUTION DETAILS

### Pre-Execution Checklist
- [ ] CPI data released (8:30 AM ET) - assess market reaction
- [ ] Check pre-market volume and price action
- [ ] Verify no material news since research generation
- [ ] Confirm stop loss orders will be placed immediately after fills

### Execution Priority
1. **8:30 AM**: Monitor CPI release, wait 5-10 minutes for initial reaction
2. **9:30 AM**: Market open - execute highest confidence trades first
3. **9:35 AM**: Place GTC stop loss orders for all fills
4. **10:00 AM**: Check fill status, adjust unfilled limit orders if needed

### Risk Controls
- All positions have stop losses (11% for DEE, 18% for SHORGAN)
- Position sizing enforced (8% DEE max, 10% SHORGAN max)
- DEE-BOT is LONG-ONLY (no margin, no shorts)
- Total portfolio heat monitored

---

## ü§ñ VALIDATION METHODOLOGY

**External Research** (Layer 1):
- Claude Deep Research: Fundamental analysis, catalysts
- ChatGPT Deep Research: Tactical entries, risk-defined setups

**Multi-Agent Validation** (Layer 2):
- FundamentalAnalyst: Financial health, valuation
- TechnicalAnalyst: Entry/exit prices, support/resistance
- NewsAnalyst: Catalyst verification
- SentimentAnalyst: Market positioning
- BullResearcher: Bull case validation
- BearResearcher: Bear case challenges
- RiskManager: Position sizing, portfolio limits, veto authority

**Consensus** (Layer 3):
- Weighted voting across agents
- Combined confidence = 40% external + 60% internal
- Approval threshold: 55% combined confidence

---

*Generated by AI Trading Bot Multi-Agent System*
*Execution via execute_daily_trades.py*
